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Abstract Members of the Id family of helix-loop-helix proteins
are ubiquitously expressed and dimerize with members of the
class A and class B basic helix-loop-helix proteins. Due to the
absence of a basic region, Id proteins act as dominant-negative
antagonists of basic helix-loop-helix transcription factors, which
regulate cell growth and differentiation in diverse cell types.
Recent findings suggest that the functions of Id proteins are well
regulated at both the transcriptional level and the post-
transcriptional level. We show here that the alternative splicing
variant of human Id-1 protein possesses a different binding
specificity for basic helix-loop-helix transcription factors and is
expressed in a cell cycle-dependent manner. Therefore, alter-
native splicing of Id-1 could provide a post-transcriptional
mechanism to regulate Id-1 function.
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1. Introduction
The helix-loop-helix (HLH) transcription factor Id plays
important roles not only in suppressing cellular di¡erentiation
but also in promoting cell growth and apoptosis [1]. Members
of the Id family proteins, Id1^Id4 in mammalian cells, have
highly homologous HLH domains but lack the basic DNA
binding region [2^10]. Thus, Id proteins bind to basic-helix-
loop-helix (bHLH) transcription factor though the HLH do-
main and heterodimerization with bHLH proteins renders the
bHLH protein incapable of binding to the E-box sequence
(CANNTG) of DNA. Therefore, Id proteins are considered
to be a dominant negative HLH transcription factor. In gen-
eral, Id proteins are highly expressed in growing cells and
their expression is down-regulated upon di¡erentiation in
many cell types. Several lines of evidence also suggest that
Id proteins play a role in the G0 to S phase transition of
the cell cycle. Stimulation of quiescent ¢broblasts with growth
factors induces the transcription of Id1, Id2 and Id3 [4,6,7] ;
inhibiting Id protein synthesis by antisense oligonucleotides
prevents the re-entry of arrested cells into the cell cycle
[7,11]; and Id expression declines as senescent ¢broblasts
lose their proliferative activity [7].
Although Id proteins are transcriptionally well regulated
during the progression of the cell cycle, recent ¢ndings dem-
onstrated that Id proteins are also regulated by post-transcrip-
tional mechanisms. Id-2 and Id-3 proteins share a conserved,
functional phosphorylation site for cyclin E and cyclin A-
CDK2 at Ser5 [12,13]. Phosphorylation of Id-2 and Id-3 pro-
teins by CDK2 alters their binding speci¢city in the late G1 to
S phase of the cell cycle [1]. CDK2 is believed to be an im-
portant kinase in the regulation of the G1 to S phase transi-
tion in the mammalian cell cycle [14,15]. Therefore, these lines
of evidence provide a link between CDKs and bHLH tran-
scription factors that may be critical for the regulation of cell
proliferation and di¡erentiation. A potential CDK2 phos-
phorylation site is present at the same position in Id-4, intri-
guingly, not in Id-1 (for a review, see [1]). Id-1 is known to
have an alternative splicing variant in human, Id-1P [7], and in
mouse, Id-1.25 [16,17].
In this report, we describe the expression pattern and func-
tional activity of both human Id-1 and its alternative splicing
product, Id-1P. We show here that the expression patterns of
both Id-1 mRNAs are very similar, although the level of Id-1P
mRNA is 5 times lower than that of Id-1 throughout the cell
cycle in human primary ¢broblasts. Moreover, the binding
speci¢city of Id-1 and Id-1P to bHLH proteins is signi¢cantly
di¡erent. These results suggest that, although Id-1 is not regu-
lated by CDK2, the activity of Id-1 is post-transcriptionally
regulated by alternative splicing.
2. Materials and methods
2.1. Analysis of Id-1 mRNA
Early passage human diploid ¢broblasts (HDF), TIG-3 cells, were
cultured in low serum (0.2%) medium for 4 days, and then cells were
treated with high-serum medium (20%). Total RNA was prepared by
extraction in guanidium isothiocyanate, phenol, and chloroform [18]
with TRISOL (Gibco-BRL). RT-PCR was performed using a Super-
Script preampli¢cation system (Gibco-BRL). The forward (F) and
reverse (R) primers for Id-1/Id-1P were ACCCTGCCCCAGAACCG-
CAAG (Primers F), TTTCCAGGCTCCTTAGGCAC (Primer R1)
and TTGTTCTCCCTCAGATCCG (Primer R2). The 5P and 3P prim-
ers for G3PDH were ACCACAGTCCATGCCATCA (Primer
G3PDH 5P) and TCCACCACCCTGTTGCTGTA (Primer G3PDH
3P).
2.2. Electrophoretic mobility shift assays
Unlabeled proteins were synthesized by couples transcription and
translation of plasmid DNA using the TNT expression system (Prom-
ega). Samples (5 Wl) of the di¡erent translation reactions were mixed
and used for DNA-binding assays. An E-box consensus sequence
(CANNTG) from the muscle creatine kinase gene enhancer was
used in all DNA-binding reactions. Two complementary oligonucleo-
tides, 5P-GGATCCCCCCAACACCTGCTGCCTGA-3P and 5P-TC-
AGGCAGCAGGTGTTGGGGGGAT-3P, were annealed and labeled
with [K-32P]dCTP using the Klenow fragment of E. coli DNA polym-
erase. Two equivalent oligonucleotides containing a mutated E-box
sequence, i.e. 5P-GGATCCCCCCAAACTGGTCTGCCTGA-3P, were
used as competitors in some experiments. DNA binding reactions
were done in a total volume of 20 Wl containing 20 mM HEPES,
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pH 7.6, 50 mM KCl, 1 mM dithiothreitol, 1 mM EDTA, 5% glycerol,
1 Wg of soluble-stranded poly(dI:dC) and 0.2 ng of labeled double-
stranded probe, at room temperature for 10 min, and for a further 15
min at room temperature after addition of the labeled probe. The
binding reactions were then subjected to electrophoresis in a 6% poly-
acrylamide gel in 25 mM Tris base, 25 mM boric acid and 0.5 mM
EDTA (0.5U TBE) at 150 V for 2 h at room temperature. The gels
were dried and the labeled complexes were detected by autoradiogra-
phy.
2.3. Puri¢cation of bacterially expressed Id proteins
The human Id-1 and Id-1P coding sequences were cloned into the
pRSET-B vector (Invitrogen) for expression in bacteria. The recombi-
nant proteins were expressed in Escherichia coli BL21(DE3)pLysS.
Histidine-tagged Id proteins produced in the pRSET-B vector were
puri¢ed on nickel-charged chelating agarose as recommended by the
supplier (Invitrogen).
3. Results and discussion
We previously identi¢ed an alternative splicing variant of
the human Id-1 gene, Id-1P [7]. Our previous work suggested
that Id-1 mRNA is barely detectable in quiescent early pas-
sage HDF; serum coordinately induced mRNA, with two
peaks of expression in early and late G1 [7]. However, due
to its genomic organization, Id-1P mRNA is di⁄cult to dis-
tinguish from Id-1 mRNA by Northern blot analysis (Fig. 1)
[19,20]. Therefore, we performed an RT-PCR analysis using
speci¢c primers. Fluorescence activated cell sorter (FACS)
analysis suggests that the peak of S-phase is around 24 h after
serum stimulation. As shown in Fig. 2, lane 1, both cDNAs
corresponding to the Id-1 and Id-1P are undetectable in qui-
escent HDF, TIG-3 cells, but are induced about 20-fold with-
in 2 h of serum stimulation. They then decline as the cells
progress through G1, and rise again around the S phase.
Although the level of cDNA corresponding to Id-1P was
5 times lower than that of Id-1, Id-1P showed a similar ex-
pression pattern during the progression of the cell cycle. This
is consistent with the numbers that were obtained when we
cloned Id-1 and Id-1P cDNA clones from a TIG-3 cell cDNA
library [7]. PCR products were con¢rmed by Southern blot
analysis using a 32P-labeled Id-1 cDNA probe (data not
shown). Moreover, synthesized cDNAs were also subjected
to PCR using G3PDH primers as a control (Fig. 3, bottom
panel). The same results were obtained with two di¡erent
combinations of PCR primers (F/R1 and F/R2), suggesting
that our RT-PCR assay was reliable (Fig. 2, top panel and
middle panel).
Although the amino acid sequence of human Id-1 is very
similar to that of mouse Id-1, there is only a limited homology
between the C-terminal region of human Id-1P and that of
mouse Id-1.25 (Fig. 3). Therefore, we examined the functional
activity of human Id-1 and Id-1P by the electrophoretic mobi-
lity shift assay (EMSA) as previously reported [12]. A 32P-
labeled MCK-E-box DNA probe was incubated with a 1:1
mixture of vE12 (a partial fragment of the E12 protein that
includes the bHLH region (residues 508^654)) and MyoD
protein which were translated in vitro. As we have previously
reported, two DNA binding complexes were observed: one
consists of a vE12 homodimer (lower band) and the other
consists of a heterodimer of vE12 and MyoD [12]. Addition
of an excess amount of unlabeled MCK-E-box oligonucleo-
tide completely abolished the formation of complexes on the
labeled probe, whereas an oligonucleotide containing a mu-
tated E-box sequence did not (see previous report [12]). To
examine the activities of the Id-1 and Id-1P proteins, we added
di¡erent amounts of recombinant Id proteins to the mixture
of the vE12 and MyoD proteins. Approximately 0.5^1 ng of
recombinant Id-1 protein was enough to inhibit the formation
of a vE12-MyoD-DNA complex (Fig. 4, lanes 3 and 4) where-
as 5- to 10-fold more Id-1P protein (V5 ng) was required to
obtain the same e¡ect on the heterodimer (Fig. 4, lane 11). In
contrast, the addition of 20 ng of Id-1P protein was able to
inhibit the formation of the homodimer vE12-vE12-DNA
complex, whereas disruption of the homodimer complex was
not observed with 20 ng of Id-1 protein (Fig. 4, lanes 7 and
13). Similar EMSA assays were then performed using vE12
alone. Recombinant Id-1 and Id-1P proteins were added to the
vE12 protein. As shown in Fig. 5, the addition of 5 ng of Id-
1P protein inhibited the formation of the homodimer vE12-
vE12-DNA complex and 25 ng of Id-1P protein completely
abolished the complex formation (Fig. 5, lane 7). However, 5-
fold more Id-1 protein was required to obtain the same e¡ect
on the homodimer (Fig. 5, lanes 4 and 6). A similar di¡erence
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Fig. 2. Comparison of mRNA expression between Id-1 and Id-1P.
Quiescent TIG-3 cells were stimulated by the addition of serum and
total RNAs were prepared at the indicated times after serum addi-
tion. One microgram of total RNA was used for RT-PCR using dif-
ferent combinations of PCR primers. Primers F and R2 (top panel);
Primers F and R1 (middle panel); Primers for G3PDH (bottom
panel).
6
Fig. 1. Organization of the human Id-1/Id-1P gene. The map shows the 7.5-kb fragment containing the human Id-1/Id-1P gene, indicating the
positions of the TATA box and polyadenylation sites. Shown below the map are the exons (small solid bars) and an intron, the Id-1/Id-1P pre-
mRNA, and the Id-1 and Id-1P proteins (large open square bars) which di¡er at the C-terminus due to di¡erential splicing of the intron. The
cDNA sequence and predicted amino acid sequence of the two isoforms of human Id-1 and Id-1P are shown below the map. The DNA sequen-
ces that were used for the RT-PCR analysis are shown as Primers F, R1 and R2.
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was observed between Id-1 and Id-2 proteins in our previous
report [12]. Although Id-1P protein is identical to Id-1 protein
except for the C-terminal 13 amino acids, the activity of Id-1P
protein is very similar to that of Id-2 protein [12]. These
results indicate that the speci¢city of Id-1 for binding to
bHLH protein could also be regulated by the C-terminal re-
gion of the Id proteins. Therefore, alternative splicing might
be an important mechanism for regulating the binding specif-
icity of Id-1 protein. It has been suggested that Id-1 protein
also binds to a novel protein, MIDA1, which does not have
the bHLH motif [21]. Thus, it would be interesting to know
how Id-1P binds to MIDA1.
The data presented here suggests that although Id-1 is not
regulated by CDK2, the activity of Id-1 is regulated by alter-
native splicing. Deed et al. [22] reported similar results for Id-
3 and its alternative splicing variant, Id-3L. Therefore, alter-
native splicing could be an important mechanism in the reg-
ulation of the functions of Id proteins.
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Fig. 4. Di¡erential activity of Id-1 and Id-1P proteins. The vE12
form of E12 and MyoD were synthesized by in vitro translation
and tested for the ability to bind to the MCK promoter E-box oli-
gonucleotide in an electrophoretic mobility shift assay. The positions
of the free 32P-labeled probe and homo- and heterodimeric com-
plexes are indicated on the right (lane 1). A similar assay was per-
formed using vE12 and MyoD together with 0.1, 0.5, 1.0, 5, 10 or
20 ng of bacterially synthesized, histidine-tagged Id-1 or Id-1P pro-
tein (lanes 2^13).
Fig. 3. Schematic representation of the structure and predicted amino acid sequences of Id-1 and the spliced variant Id-1P. The relative posi-
tions of the regions common to Id-1 and Id-1P, encompassing the HLH domain, are depicted by open boxes, and the amino acid sequences of
the carboxyl termini unique to each protein are shown.
Fig. 5. E¡ects of Id-1 and Id-1P proteins on vE12 homodimeric
bHLH-E box binding. EMSA was performed using in vitro trans-
lated vE12 protein, and complexes were challenged with increasing
inputs of bacterially synthesized, histidine-tagged Id-1 or Id-1P pro-
teins. The positions of the free 32P-labeled probe and homodimeric
complexes are indicated on the right.
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